View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Uncovering miRNA-mediated Adipose-Brain Crosstalk in Alzheimer’s Disease

Marcelo A. Mori, Ph.D.
Campinas, Brazil
2023

Inclusive ADRD Clinical Trials: Screening, Enrolling Latino Participants

G. Adriana Perez, Ph.D.
Philadelphia, PA - United States
2023

Pyroptosis-induced gut-brain disruption after Stroke in Alzheimer’s disease

Nadine Ahmed Kerr, Ph.D.
Miami, FL - United States
2023

Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models

Moustafa Algamal, Ph.D.
Boston, MA - United States
2023

Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes

Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023

Identifying Astrocyte-Mediated Vasomotion Underlying AD Pathogenesis

Xiaoqing Alice Zhou, Ph.D.
Boston, MA - United States
2023

Uncovering the Role of SORL1 as a Key Regulator of AD Endosomal Pathology

Brooke Alisen DeRosa, Ph.D.
Miami, FL - United States
2023

Influence of the Microenvironment on the Turnover of Fluid Biomarkers

Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023

Interrogating Metabolic Dysregulation in Neurodegeneration Using Organoids

Madeline Andrews, Ph.D.
Tempe, AZ - United States
2023

Kv7 K+ channels, BACE1, APP, and Alzheimer's disease-related epilepsy

Fabio Antonio Borges Vigil, Ph.D.
San Antonio, TX - United States
2023

Multi-Omics Characterization of a Diverse Population in the South of Brazil

Marco Antônio De Bastiani, Ph.D.
PORTO ALEGRE, Brazil
2023

Targeted Network Attack in Assessing Brain Resilience

Georgette Argiris, Ph.D.
New York, NY - United States
2023

The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction

Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023

Assessing Meaningful Engagement in Advanced Dementia (MEAD)

Arlene Astell, Ph.D.
Toronto, Canada
2023

A CRISPR-Based Therapeutic for Alzheimer's disease

Brent Aulston, Ph.D.
La Jolla, CA - United States
2023

Circuit Targets to Rescue Memory Functions in Alzheimer’s Disease

Jayeeta Basu, Ph.D.
New York, NY - United States
2023

Underlying effects of ApoE variants on brain pericytes in CAA and AD

Praveen Bathini, Ph.D.
Boston, MA - United States
2023

AD Nanomedicines Targeting Vasculature Disfunction and Neuroinflammation

Giuseppe Battaglia, Ph.D.
Barcelona, Spain
2023

A Deep Learning Tool to Generalize Tau PET to Predict AD progression

Guilherme Bauer Negrini, Ph.D.
Pittsburgh, PA - United States
2023

Determining the Impact of Tau Aggregates on Neuron Loss with 2P Imaging

Rachel Bennett, Ph.D.
Boston, MA - United States
2023

Mechanisms of Complement Mediated Synaptic Removal Following Tauopathy

Matthew Benskey, Ph.D.
Grand Rapids, MI - United States
2023

Uncovering Mechanisms of Neuronal Hyperexcitability in Tauopathies

Steven Boggess, Ph.D.
San Francisco, CA - United States
2023

Blood Redox Biomarker for Dementia

Gregory Brewer, Ph.D.
Irvine, CA - United States
2023

Individualized Prediction of Tau Propagation Using Diffusion Tensor Imaging

Christopher Brown, Ph.D.
Philadelphia, PA - United States
2023

Nanotau

Luc Buée, Ph.D.
Lille, France
2023

Patterns & Preferences of Home-Based Service Use for Persons with Dementia

Dr. Julia Burgdorf, Ph.D.
New York, NY - United States
2023

Uncovering Mechanisms of Axonal Pathology in Alzheimer's disease

Yifei Cai, Ph.D.
New Haven, CT - United States
2023

Continued Development of the Next Generation Environmental Assessment Tool

Margaret P Calkins. Ph.D.
Cleveland Heights, OH - United States
2023

Resolving Cellular Resilience and Resistance to Alzheimer’s Disease

Isabel Castanho, Ph.D.
Boston, MA - United States
2023

Combined Lecanemab Immunotherapy and BDNF Gene Therapy for AD

Michael J. Castle, Ph.D.
San Diego , CA - United States
2023

1 2 3 4 5 6 7 8 9 10... >|